Spectroscopic Estimation of Pioglitazone Hydrochloride

Table of contents

1.

glucose, decreases withdrawal of glucose from the liver, and reduces quantity of glucose. [2] .HCl According to literature review, a HPLC method for the estimation of Pioglitazone hydrochloride is available. [3] The method is relatively complex and expensive. The UV method for estimation of Pioglitazone hydrochloride in methanol: water: hydrochloric acid (250:250:1) system [4] and in 0.2 M sulphuric acid [5] have been reported. However, quantitative estimation of PH in other media has not been reported. This is essential in drug release study. The objective of the study was to develop a simple, accurate, precise, cost effective and reproducible UV method for estimation of PH in 0.1N hydrochloric acid as per ICH guidelines. [6] Shimadzu UV/Visible double beam spectrophotometer and a Jasco V-630 instrument with 1 cm matched quartz cells were used for the spectral measurement. Shimadzu AX200 analytical balance was used for the weighing purpose. The reference standard of PH was obtained as a gift sample from Aarti Drugs, Thane (India) with 99.8% assay value. PH tablets (Piomed, 15 mg) were obtained from the market and utilized for the study. All other chemicals were of analytical grade.

2. a) Selection of The Media

The criterion for selection of the medium was the solubility and the stability, i.e. PH should be soluble Standard solution of PH was prepared by dissolving 100 mg of drug in 100 ml of 0.1N hydrochloric acid (Solution A, 1000 µg/ml). Further 10 ml of the solution A was diluted to 100 ml with 0.1N hydrochloric acid (Solution B, 100 µg/ml). Solution B was used as the standard stock solution.

3. c) Preparation of Calibration Curve

Aliquots of 1 ml to 7 ml of the standard solution B were transferred into a series of calibrated 10 ml standard volumetric flasks and the final volume was made up using 0.1N hydrochloric acid. The solutions were scanned in the range of 200-400 nm against blank (0.1N hydrochloric acid). The absorption maximum was found to be at 269 nm. (Figure 2)The absorbance of the solutions were measured at 269 nm against the blank (Table 1) and the calibration curve was constructed. (Figure 3) The proposed method was applied to marketed PH tablets (Piomed, 15 mg). Twenty tablets of PH were weighed and powdered in a glass mortar. Powder equivalent to 100 mg of the drug was weighed accurately and transferred to a 100 ml standard volumetric flask. It was dissolved in about 50 ml of 0.1N hydrochloric acid and the volume was made up with 0.1N hydrochloric acid so that the concentration was 1000 µg/ml (Solution P). Ten ml of the solution P was transferred to a 100 ml standard volumetric flask and the volume was adjusted with 0.1N hydrochloric acid (Solution Q). The solution was filtered through Whatmann filter paper no. 41. The filtrate was diluted suitably with 0.1N hydrochloric acid to obtain a sample solution (20µg/ml). The absorbance of the sample solution was measured at 269 nm and the amount of PH was determined from the calibration curve. The method was studied for accuracy and precision. a) Linearity Pioglitazone hydrochloride exhibited maximum absorption at 269 nm and obeyed Beer's Law in the range of 10-70 µg/ml. [8,10] Linear regression of absorbance Vs concentration yielded equation y= 0.022x + 0.017 with a correlation coefficient of 0.999.

4. b) Accuracy

To determine the suitability and reproducibility of the proposed method, recovery studies were carried precision, the % drug content and the relative standard deviation (RSD) values 99.59722 ± 0.4722, 100.7488 ± 0.4522, 100.4226 ± 0.5617 and 0.4940 respectively. When the analyst was changed the RSD values were 0.48225 and 0.4662. According to ICH guidelines, an acceptance criterion for the precision is RSD ? 2%.

out by adding known amount of standard PH (80%, 100%, and 120%) to the tablet solution P and analyzing the mixtures by the proposed method. Three samples were prepared for each recovery level. The percentage recovery of PH was found to be 99.3233 ± 0.7026 (Table 3) indicating that there is no interference by the excipients in the method. According to ICH guidelines, an acceptance criterion for the % recovery is 98-102%.

5. c) Precision

Precision of the method was demonstrated by intra-day and inter-day variation studies. For intra-day precision, six sample solutions of Pioglitazone hydrochloride of same concentration (20µg/ml) were analyzed three times in a day. The result is indicated by % RSD in Table 4.

During the intermediate precision (inter-day precision), six sample solutions of the same concentration (20µg/ml) were analyzed on three consecutive days and by two different analysts in same laboratory. The results are indicated by % RSD in Table 5 and 6.

For intra-day precision, the % drug content and the relative standard deviation (RSD) were found to be 99.958 ± 0.7874, 99.928 ± 1.104, 99.297 ± 1.114 and 1.0087 respectively; whereas for inter-day When the analysis was carried on two different instruments, the RSD values were 0.5297 and 0.5213. The LOD and LOQ of PH were determined by using standard deviation of the response and the slope approach as defined in the ICH Guidelines [6]. The LOD and LOQ were found to be 0.03µg/ml and 0.1µg/ml respectively. The proposed method showed molar absorptivity of 9.6013 × 104 l/mol.cm. (Table 2)

6. March

Figure 1. Figure 1 :
1Figure 1: Chemical Structure of Pioglitazone hydrochloride
Figure 2. A
the medium for sufficient time during the study. Methanol: water: hydrochloric acid (250:250:1) was used in the reported method. Dissolution studies recommend 0.1N hydrochloric acid. Hence 0.1N hydrochloric acid was selected as the analytical medium for the present work.b) Preparation of Standard Solution
Figure 3. Figure 2 :Figure 3 :
23Figure 2 : Pioglitazone hydrochloride absorbance spectrum
Figure 4. Table 1 :
1
Sr. Concentration Absorbance Standard
no (µg/ml) deviation
1 0 0 0
2 10 0.2380 ± 0.003551
3 20 0.4620 ± 0.003404
4 30 0.7385 ± 0.003593
5 40 0.9034 ± 0.002524
6 50 1.1134 ± 0.000917
7 60 1.3600 ± 0.001000
8 70 1.5359 ± 0.002571
Figure 5. Table 2 :
2
Sr Parameter Result
no
1. Absorption maxima 269 nm
2. Linearity range 10-70 µg/ml
3. Standard Regression y = 0.022x + 0.017
Equation
4. Correlation 0.999
coefficient (r 2 )
5. Molar Absorptivity 9.6013 × 10 4 l/mol.cm
6. A (1%, 1 cm) 244.328 dl/gm/cm
7. Accuracy (% 99.3233 ± 0.7026
recovery ± S.D)
8. Specificity A 20 µg/ml of drug in
0.1 N HCl at UV
detection wavelength
of 269 nm shows an
absorbance value of
0.4620 ± 0.003404
9. LOD (µg/ml)) 0.03
10. LOQ (µg/ml) 0.10
d) Preparation of Sample Solution
Figure 6. Table 3 :
3
Ingredient Pioglitazone hydrochloride
Tablet amount 20 20 20
(µg/ml)
Level of 80 100 120
addition (%)
Amount added 16 20 24
(µg/ml)
Amount 35.748 39.574 44.1288
recovered
(µg/ml)
% Recovery 99.3000 98.9350 100.2927
Average % 99.3233 ± 0.7026
recovery
Figure 7. Table 4 :
4
hydrochloride
Sample Analysis of Pioglitazone
Number hydrochloride as percent of drug
content
10:00 am 2:00 pm 6:00 pm
1 101.214 98.979 98.569
2 99.458 99.568 100.598
3 99.587 99.259 99.454
4 100.254 101.871 100.598
5 98.979 99.298 97.995
6 100.256 100.598 98.568
Mean ± 99.958 ± 99.928 ± 99.297
SD 0.7874 1.104 ± 1.114
Average 99.7276 ± 1.00875
± RSD 1.0087
Figure 8. Table 5 :
5
hydrochloride
Sample Analysis of Pioglitazone hydrochloride
number as percent of labeled content
DAY-1 DAY-2 DAY-3
1 99.8467 100.725 100.053
2 100.0230 101.146 99.8792
3 99.4538 99.9875 99.9103
4 98.9985 100.5473 101.163
5 99.1356 100.856 100.5409
6 100.1257 101.231 100.9892
Mean ± 99.59722 ± 100.7488 ± 100.4226 ±
SD 0.4722 0.4522 0.5617
Average 100.2562 ± 0.4940
± RSD 0.4940
Figure 9. Table 6 :
6
(Intra-day precision)
Sample Analysis of Pioglitazone
number hydrochloride as percent of
labeled amount
Analyst-I Analyst-II
1 100.2346 99.1035
2 100.9812 99.1418
3 99.8754 98.7460
4 100.0213 99.2435
5 99.5381 97.9924
6 100.1509 98.6356
Mean 100.1335 98.8149
Std. 0.48225 0.4662
Deviation
d) Robustness
Figure 10. Table 7 :
7
Instruments)
Sample Analysis of Pioglitazone
number hydrochloride as percent of
labeled content
Shimadzu Jasco
1 99.184 100.231
2 98.793 101.104
3 99.862 100.863
4 100.021 99.982
5 98.795 101.016
6 99.568 99.989
Mean 99.3705 100.5308
Std 0.5297 0.5213
Deviation
e) Limit Of Detection (LOD) And Limit of Quantitation
(LOQ)
57

Appendix A

Appendix A.1

The developed method was found to be simple, accurate, precise, reproducible and can be used for dissolution studies and routine quality control analysis of PH in bulk and in tablet form.

We are thankful to Padmashree (Mrs.) Fatma Rafiq Zakaria, Honorable Chairman of Maulana Azad Educational Trust, Dr. Rafiq Zakaria Campus, Aurangabad for providing the research facilities. We are also thankful to Aarti Drugs Ltd., Thane for providing the gift sample of Pioglitazone hydrochloride.

Appendix B

  1. , Amr Lotfy , Saber . Pak J Anal Environ Chem 2008. 9 (2) p. .
  2. H A Lieberman , L Lachman . Pharmaceutical Dosage Forms: Tablets Volume, (Ed, New York
    ) 1990. Markel Dekker Inc. 3 p. .
  3. ICH Text on Validation of analytical procedures, 2007. 2.
  4. Spectroscopic estimation of Pioglitazone HCL in tablet dosage form. P K Basniwal , P K Shrivastava , D Jain . Asian Journal of Pharmaceutics Oct-Dec 2008. p. .
  5. UV and visible spectrophotometric analysis of Pioglitazone in bulk and tablet dosage form. R S Mehta . Indian Journal of Pharmaceutical Sciences July-Aug 2005. p. .
  6. The Merck Index, An encyclopaedia of chemicals, drugs and biological, S Budavari , M O'neil , A Smith , P Heckelman . 2001. New Jersey: Merck and Co. 799 p. . (13th edition)
  7. Basic concepts of Analytical Chemistry. S M Khopkar . New Age International Publisher 2008. p. . (3rd edition)
  8. Validated UV method for the dissolution of mycofenolate mofetil tablets. S P Verma , O Alam , P Mullick , N Siddiqui , S A Khan . Nature Preceding 2009. p. .
  9. Pioglitazone: mechanism of action. U Smith . Int J Clin Pract Suppl 2001. 121 p. .
  10. Validation of Analytical Procedures; Methodology (Q2B) Harmonized Tripartite Guidelines, 1996. p. 1.
Notes
57.
Volume XII Issue II Version I © 2012 Global Journals Inc. (US) March
Date: 2012-02-22